Tissue plasminogen activator (tPA) antigen in plasma: correlation with different tPA/inhibitor complexes

Area of Science:

• Biochemistry
• Cardiovascular Research
• Protease Inhibitor Interactions

Background:

• Tissue plasminogen activator (tPA) antigen is a known predictor of myocardial infarction.
• The majority of plasma tPA antigen exists as inactive complexes with inhibitors, not active tPA.
• Understanding these complexes is crucial for accurate cardiovascular risk assessment.

Purpose of the Study:

• To develop and validate specific two-site ELISA methods for quantifying individual protease/inhibitor complexes involving tPA.
• To measure concentrations of tPA complexes in plasma from healthy individuals.
• To investigate correlations between tPA antigen, its complexes, and PAI-1 activity.

Main Methods:

• Development of specific two-site ELISA assays for tPA/PAI-1, tPA/antiplasmin, and tPA/C1 inhibitor complexes.
• Plasma samples from 30 healthy individuals were analyzed.
• Quantification of tPA antigen using a commercial kit and PAI-1 activity concentration.

Main Results:

• A strong correlation was observed between tPA/PAI-1 complex concentration and total tPA antigen levels.
• Significant correlation found between tPA/PAI-1 complex levels and PAI-1 activity.
• No significant correlations were detected between tPA antigen and tPA/C1 inhibitor or tPA/antiplasmin complexes.

Conclusions:

• The tPA/PAI-1 complex is the primary component contributing to total tPA antigen in plasma.
• Specific ELISA methods enable differentiation of tPA complexes, offering a more nuanced understanding of tPA status.
• These findings advance the characterization of tPA and its inhibitors in cardiovascular health.